The Spanish Society of Medicinal Chemistry (SEQT) is organising the XIIth SEQT Mini Symposium. IIIrd Spanish/Portuguese/Brazilian Meeting, scheduled to be held on November 17-18th 2016 at GSK R&D facilities in Tres Cantos (Madrid, Spain). The topic of this joint meeting will be “Medicinal Chemistry of Tropical Diseases”.

Read more

Confirmed speakers

Dr David Barros, Head of Tuberculosis DPU, DDW, GSK - Development of New drugs for the Treatment of MDR-TB"

Synopsis: The objective of the one-day symposium is to delve into the latest developments around Positron Emission Tomography (PET) and Imaging as invaluable non-invasive translational evaluation and diagnostic tools in drug discovery. Medicinal Chemistry now plays a critical role in the design, the synthesis and the characterization of suitable ligands with very specific properties. A sightseeing tour around state-of-the-art synthetic methodologies, tracers design and optimization principles, recent applications and perspectives in various therapeutic areas as well as selected case-studies will be presented.

The closing date for early-bird registration and submission of poster abstracts is now passed but it is still possible to register!

This symposium will feature an international line up of speakers presenting on the discovery and development of novel therapeutic agents that have recently progressed towards or into clinical trials.

Read more

The symposium will start with the 2016 Society of Medicines Research Award Lecture (the details of which will be announced in September) followed by the presentation of the award. The programme will also include a variety of mechanistic approaches for the novel therapeutics including small molecules, monoclonal antibodies and a drug repurposing presentation and will cover therapeutics areas including oncology, anti-infectives, inflammation and anaemia.

Fees:£85 member rate £135 non member rate

To become a member and register for the event, pay the special fee of £110

Call for Nominations - EFMC Prizes 2017

To acknowledge and recognise an outstanding young medicinal chemist (≤ 12 years after PhD) working in industry or in academia within Europe, EFMC established the EFMC Prize for a Young Medicinal Chemist in Industry and the EFMC Prize for a Young Medicinal Chemist in Academia.

Read more

The Prizes will consist of a diploma, € 1.000 and an invitation for a short presentation at the VII EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC’17), August 27-31, 2017, Vienna (Austria).

News from EuCheMS

The Seville International Chemistry Declaration 2016, was signed in Seville at the 6th EuCheMS Chemistry Congress on September 13th, 2016

Read more

The Seville International Chemistry Declaration 2016, was signed in Seville at the 6th EuCheMS Chemistry Congress on September 13th, 2016, having as its first signatories Carlos Negro (Foro Química y Sociedad President and Co-Chairman of ECC6), Jean Marie Pierre Lehn (Nobel Laureate), Antón Valero (President of Spanish Chemical Industry Federation), Ehud Keinan (President of EuCheMS Member, the Israel Chemistry Society), Robert Parker (CEO of the EuCheMS Member, the UK Royal Society of Chemistry) and Harmut Frank (University of Bayreuth, and Chair of EuCheMS Working Party of Ethics in Chemistry).

You are kindly invited to spread the link amongst your members for on-line signing.

Job announcements

In a continuous effort to improve our services for the Medicinal Chemistry community, EFMC will now be offering information on current vacant positions advertised on the EFMC website via the monthly newsletter, MedChemWatch.

Read more

Please find below a list of job offers in the field of medicinal chemistry.

To continue the commemoration of his outstanding contributions in a broad range of chemistry and their application to the understanding of bioactivity, the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry is proud to invite nominations for the eighth Malcolm Campbell Memorial Prize. The prize will be awarded to the individual or team based in UK academia or industry who, in the judgement of the BMCS committee, has made the most significant scientific contribution to biological chemistry. Nominations could be from either discovery and/or process development and include medicinal, agrochemical or aromachemical research. The work should be timely and contemporaneous. A medal and certificate will be awarded to accompany the prize of £2000

Late Stage Functionalization for Synthesis and Medicines, 5th December 2016, University of Oxford, Oxford, UK

Synopsis: LSF holds the potential to revolutionise the logic of chemical synthesis and open new ways to prepare novel natural products and medicines. The availability of new powerful catalytic chemistries showing a high degree of functional group tolerance and that can be performed under mild conditions offer tremendous opportunities for chemists to access new molecules that cannot be made easily by conventional approaches.

Synopsis: The event is aimed at all scientists (students, post-docs, academics, industrialists) engaged in research on protein-protein interactions, alongside those interested in finding out more about this topic. The meeting programme will appeal to chemists, biologists and the wider drug-discovery community.

Prizes FIGON Dutch Medicines Days – delegate EFMC-YMCS 2017 During the FIGON Dutch Medicines Days, a two-day national symposium on drug development and medicines, the division Medicinal Chemistry of the Royal Netherlands Chemical Society awarded a presentation prize (€ 500) and poster prize (€ 250) to young researchers in medicinal chemistry.

Read more

The presentation prize was awarded to Mr M. Yagiz Ünver of the group of Prof. Dr Anna Hirsch of the University of Groningen for the talk entitled ‘Expanding the Toolbox of Protein-templated Reactions for Hit Identification’. Yagiz Ünver started his PhD in October 2013 and his research interests are focused on novel applications of dynamic combinatorial chemistry (DCC) for the identification and optimisation of inhibitors. He will be the Dutch delegate for the EFMC-YMCS 2017 in Vienna, where he will present his results obtained in his PhD study.

The poster prize was awarded to Mrs. Lindsey Burggraaff of the group of Prof. Dr Ad IJzerman of the LACDR/Leiden University for the poster entitled ‘Predicting SGLT1 Compound Activity with Proteochemometric Modeling’. In her PhD study she works on a computational approach to predict target selectivity of ligands.